Every A/B test rests on a statistical framework, and there are two: frequentist and Bayesian. They can analyze the same data and reach the same practical conclusion, but they ask different questions, report different outputs, and fail in different ways. Picking the right one shapes how you run tests, when you're allowed to look at results, and how confidently your team can act.
For the formal definition of the Bayesian approach, see the Bayesian A/B testing glossary entry. This article is about the practical tradeoffs — what actually changes for your team depending on which you choose.
The Fundamental Difference
The two frameworks answer different questions:
- Frequentist asks: "If there were truly no difference between variants, how surprising is the data I observed?" The answer is a p-value. A small p-value means the data would be unlikely under the assumption of no effect, so you reject that assumption.
- Bayesian asks: "Given the data I observed, what's the probability that variant B is better than A?" The answer is a direct probability: "There's an 87% chance B beats A."
That difference sounds academic, but it drives everything downstream.
Interpretation: What Stakeholders Hear
The frequentist output is notoriously easy to misread. Statistical significance at p < 0.05 does not mean "95% chance B is better" — it's a statement about how often you'd see this data if there were no effect. Nearly everyone outside of statistics quietly mistranslates it.
The Bayesian output — "87% probability B beats A" — is the statement people think the frequentist result is giving them. For communicating with marketers and executives, that directness is a real advantage: there's no gap between what the number says and what people act on.
Peeking: The Decisive Practical Difference
This is where the choice bites hardest in day-to-day testing.
Frequentist tests are built around a fixed sample size decided in advance. If you check results early and stop the moment you see significance — the peeking problem — you dramatically inflate your false-positive rate. The discipline of "don't look until you hit your sample size" is hard to enforce on an impatient team.
Bayesian methods are more robust to continuous monitoring. Because the output is a probability that updates with each observation, checking it as data arrives doesn't carry the same statistical penalty (though it's not entirely free — there are still tradeoffs around stopping rules). For teams that will look early no matter what you tell them, Bayesian methods fail more gracefully.
A nuance: sequential frequentist methods (always-valid p-values, group sequential designs) also solve peeking. So "peeking-safe" isn't unique to Bayesian — but classical fixed-horizon frequentist testing is the most peeking-fragile of the common approaches.
Priors: Power and Responsibility
The Bayesian framework lets you encode prior belief about the baseline before the test starts. Used well — a weak, uninformative prior, or a genuine estimate from past tests — this can speed up learning. Used badly, a strong incorrect prior can drag results toward a wrong conclusion. Frequentist methods sidestep this entirely by ignoring prior knowledge, which is both their weakness (they relearn from scratch every time) and their auditability advantage (there's no subjective input to argue about).
Side by Side
| Frequentist | Bayesian | |
|---|---|---|
| Core output | p-value, confidence interval | Probability B > A, credible interval |
| Question answered | "How surprising is this data?" | "How likely is B better?" |
| Interpretability | Counterintuitive, often misread | Direct and intuitive |
| Peeking (fixed-horizon) | Fragile — inflates false positives | More robust to continuous monitoring |
| Prior knowledge | Ignored | Incorporated (for better or worse) |
| Auditability | High — no subjective inputs | Lower — depends on prior choice |
| Regulated industries | Widely accepted standard | Less universally accepted |
Which Should You Use?
Choose frequentist when:
- You operate in a regulated or high-scrutiny environment (pharma, finance, anything audited) where the classical p-value is the accepted standard.
- You need a defensible, reproducible result with no subjective inputs to litigate.
- Your team has the discipline to set a sample size up front and not peek.
Choose Bayesian when:
- You need stakeholders to act on results without a statistics tutorial — the direct probability is easier to trust correctly.
- Your team will monitor tests continuously and you want a framework that tolerates it.
- You're running many tests and want to carry learning across them via priors.
The honest answer for most CRO teams: Bayesian methods tend to fit the reality of how marketing teams actually work — impatient monitoring, non-statistician stakeholders, lots of tests. That's why most modern experimentation platforms default to or offer a Bayesian mode. But the framework matters less than running tests correctly within it: adequate sample sizes, guardrail checks like sample ratio mismatch, and resisting the urge to call winners on noise.
Autonomous optimization platforms like Surface AI lean on Bayesian methods under the hood precisely because they're built for continuous, always-on learning rather than fixed-endpoint experiments — exactly the setting where the frequentist peeking problem would otherwise bite.